A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.

A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.
Conditions: Pancreatic Ductal Adenocarcinoma; Gastroesophageal Adenocarcinoma; Glioblastoma Multiforme

Interventions: Drug: 68Ga-FF58; Drug: 177Lu-FF58

Sponsors: Novartis Pharmaceuticals

**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 29, 2024Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine
Comments